PlainRecalls
FDA Drug Moderate Class II Ongoing

LidoPatch (lidocaine HCl 3.6%, menthol 1.25%) Pain Relief Patch, packaged in 1 patch/box (NDC 10882-527-01); 30 patches/box (NDC 10882-527-02 and 10882-527-04), Manufactured for: JAR Laboratories, Elmhurst, IL.

Reported: June 3, 2020 Initiated: May 19, 2020 #D-1277-2020

Product Description

LidoPatch (lidocaine HCl 3.6%, menthol 1.25%) Pain Relief Patch, packaged in 1 patch/box (NDC 10882-527-01); 30 patches/box (NDC 10882-527-02 and 10882-527-04), Manufactured for: JAR Laboratories, Elmhurst, IL.

Reason for Recall

CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.

Details

Units Affected
4,960 boxes
Distribution
Nationwide in the USA
Location
Wuhan, N/A

Frequently Asked Questions

What product was recalled?
LidoPatch (lidocaine HCl 3.6%, menthol 1.25%) Pain Relief Patch, packaged in 1 patch/box (NDC 10882-527-01); 30 patches/box (NDC 10882-527-02 and 10882-527-04), Manufactured for: JAR Laboratories, Elmhurst, IL.. Recalled by Wuhan Bingbing Pharmaceutical Co., Ltd.. Units affected: 4,960 boxes.
Why was this product recalled?
CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 3, 2020. Severity: Moderate. Recall number: D-1277-2020.